Condition
Stage IVA Hepatocellular Carcinoma AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Stage IVA Hepatocellular Carcinoma AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Stage IVA Hepatocellular Carcinoma AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
| Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment | Phase 2 | Scottsdale, Arizona and 15 other locations | Recruiting | Dec 23, 2021 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Radiation therapy followed by immune therapy for advanced liver cancer | Phase 2 | San Francisco, California | Recruiting | Jun 12, 2020 |
| Using radiation therapy to treat metastatic gastrointestinal cancers | — | San Francisco, California and 1 other locations | Recruiting | Jan 9, 2020 |
All recruiting trials (5)
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment
This study is testing if adding atezolizumab to either cabozantinib or lenvatinib can help people with advanced liver cancer live longer and feel better compared to just taking the multi-kinase inhibitor alone.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Radiation therapy followed by immune therapy for advanced liver cancer
This study is testing whether a combination of radiation therapy and immune treatments can help people with advanced liver cancer that hasn't improved after other treatments.
-
Using radiation therapy to treat metastatic gastrointestinal cancers
This study tests if adding radiation therapy to immunotherapy can help people with metastatic gastrointestinal cancers feel better and improve their disease status.
Related topics
Quick answers
How many Stage IVA Hepatocellular Carcinoma AJCC v8 clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.